Dear Reader,
Pretty soon, the pandemic will be over.
And most of our lives will go back to normal.
But there is ONE pandemic habit that will not change.
And it’s triggering a flood of money into one niche sector of the stock market.
<The 5 Tech Giants of the 2020s>
Sincerely,
Sam Latter
Editor-in-Chief
Altimetry Research
Company Overview Neumora Therapeutics (NASDAQ: NMRA) is a clinical-stage biopharmaceutical company focused on neuroscience, recently thrust into the spotlight after a major late-stage trial setback.
Daily Financial Update Good Monday morning—let’s cut through the noise and get you up to speed on what really matters. Opening Recap Market Pulse: AI
Overview & Barzolvolimab Breakthrough Celldex Therapeutics (NASDAQ: CLDX) is a clinical-stage biotech focused on immunology, and it recently drew significant attention after unveiling compelling results
